Bravecto Spot-on for Dogs
Our long-lasting protection is now even longer. Just two doses provide full year protection against fleas and paralysis ticks.
- Rest easier with 6 months protection from fleas and paralysis ticks in one Spot-on
- Treatment and control of ear mites
- Also treats and control sarcoptic mange
- Prevents flea tapeworm infections
- Our TWIST´N´USE tube makes it quick and easy to apply
Beat fleas reliably 6 months at a time
Delivering fast protection that lasts. A single treatment with Bravecto Spot-on gives your dog effective cover for a full 6 months and controls Flea Allergy Dermatitis (FAD).
Protect against the threat of paralysis ticks for 6 months
Give your dog protection from the single most dangerous tick for canines in Australia. Bravecto Spot-on for Dogs controls paralysis ticks within the critical 72 hour period following tick attachment for both new and pre-existing tick infestations.
Enjoy simple and convenient application
Our TWIST´N´USE tube makes it easy and hassle-free to apply Bravecto Spot-on, without fuss for you or your dog. It also provides a great alternative for dogs that don’t like tablets, or where longer lasting protection is required.
Bravecto can be used on puppies from 8 weeks of age, weighing at least 2 kg
Enjoy peace of mind knowing that once your puppy is old enough to enjoy an active outdoor lifestyle, they’ll be protected from the risks of fleas and paralysis ticks.
Over 100 million doses dispensed worldwide
Bravecto is proud to deliver a safe, well-tested solution for dogs and cats worldwide against paralysis ticks and fleas. Our products have undergone rigorous regulatory approval processes and are sold with confidence in over 70 countries and are determined to be safe when used according to the label.
Extensively tested and continually monitored
With comprehensive clinical research, Bravecto has been proven safe for use in breeding, pregnant and lactating dogs as well as puppies over 8 weeks of age weighing at least 2 kg.
Global safety monitoring of Bravecto use continues to provide additional compelling evidence of the safety of the product.